Staging

W Sanchez, GJ Gores - Hepatocellular Carcinoma, 2009 - taylorfrancis.com
Hepatocellular carcinoma (HCC) is a major global health problem. In the year 2000, HCC
was the third leading cause of cancer-related death worldwide, accounting for over half a …

Developing dietary interventions as therapy for cancer

SR Taylor, JN Falcone, LC Cantley… - Nature Reviews …, 2022 - nature.com
Cancer cells acquire distinct metabolic preferences based on their tissue of origin, genetic
alterations and degree of interaction with systemic hormones and metabolites. These …

[PDF][PDF] Acetate is a bioenergetic substrate for human glioblastoma and brain metastases

T Mashimo, K Pichumani, V Vemireddy, KJ Hatanpaa… - Cell, 2014 - cell.com
Glioblastomas and brain metastases are highly proliferative brain tumors with short survival
times. Previously, using 13 C-NMR analysis of brain tumors resected from patients during …

[PDF][PDF] Acetate dependence of tumors

SA Comerford, Z Huang, X Du, Y Wang, L Cai… - Cell, 2014 - cell.com
Acetyl-CoA represents a central node of carbon metabolism that plays a key role in
bioenergetics, cell proliferation, and the regulation of gene expression. Highly glycolytic or …

[HTML][HTML] Imaging and cancer: a review

L Fass - Molecular oncology, 2008 - Elsevier
Multiple biomedical imaging techniques are used in all phases of cancer management.
Imaging forms an essential part of cancer clinical protocols and is able to furnish …

Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG …

W Guo, Y Pang, L Yao, L Zhao, C Fan, J Ke… - European journal of …, 2021 - Springer
Purpose This study aimed to evaluate the potential utility of [68 Ga] Ga-FAPI-04 PET/CT for
diagnosing primary and metastatic lesions in patients with liver cancer, as well as to …

Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study

X Shi, H Xing, X Yang, F Li, S Yao, J Congwei… - European Journal of …, 2021 - Springer
Purpose This study aimed to compare the performance of 68 Ga-labelled fibroblast
activating protein inhibitor (FAPI) PET and 18 F-FDG PET for imaging of hepatic tumours …

[HTML][HTML] FAPI-PET/CT in cancer imaging: a potential novel molecule of the century

R Huang, Y Pu, S Huang, C Yang, F Yang, Y Pu… - Frontiers in …, 2022 - frontiersin.org
Fibroblast activation protein (FAP), a type II transmembrane serine protease, is highly
expressed in more than 90% of epithelial tumors and is closely associated with various …

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics

R Dhanasekaran, A Limaye… - … medicine: evidence and …, 2012 - Taylor & Francis
Hepatocellular carcinoma (HCC) is a common malignancy in developing countries and its
incidence is on the rise in the developing world. The epidemiology of this cancer is unique …

[HTML][HTML] Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases

JHMB Stoot, RJS Coelen, MC De Jong, CHC Dejong - Hpb, 2010 - Elsevier
Background Malignant transformation of hepatocellular adenomas (HCAs) into
hepatocellular carcinomas (HCCs) has been reported repeatedly and is considered to be …